Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →VR display and optics patenting is a narrow, optics-heavy field: 92 of the 98 tracked families fall under G02B, the classification for optical elements and systems, with pancake lens assemblies, varifocal mechanisms and screen-door-effect mitigation as the recurring claim subjects. A second cluster of classes — A61B, A61F, A61M and A61N — shows the same optical hardware increasingly claimed alongside diagnostic and therapeutic uses, from visual-field testing to medication delivery through the headset. That overlap is a filing strategy as much as a technical one: headset optics claimed jointly with a health application can clear novelty bars that a pure display claim cannot.
Filing activity rose steadily from a single family in 2017 to a peak of 17 in 2022, then eased off. Because publication trails filing by roughly eighteen months, the most recent years understate real activity, but the shape of the curve — a rise to a mid-period high rather than a still-climbing line — points to a field where the core optical architectures are already staked out rather than still being defined.
98 patent families published between 2015 and mid-2026, drawn from a search combining VR display and optics terms with pixel-density, latency and varifocal language in the claims.
From one family in 2017 to 17 in 2022, then falling back — a pattern consistent with an optical architecture (pancake lenses, varifocal stacks) that got claimed early and hard, rather than one still attracting fresh entrants.
92 of 98 families touch G02B. The next-largest classes are not display-adjacent but health-adjacent — A61B, G06T, A61F and A61M — indicating the optical hardware is frequently claimed for diagnostic or therapeutic function, not display quality alone.
Shares are the percentage of the 98 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about vr display and optics systems and every answer comes back with the patent numbers behind it.
Try EurekaAn optical lens assembly and an optical system is provided. The optical lens assembly includes a first optical element including a partial reflector and a quarter-wave plate and a second optical element including a reflective polarizer. The first optical element and the second optical element form a cavity. The pancake lens assembly further includes a varifocal lens having an adjustable optical power, and the varifocal lens is disposed inside or outside the cavity.Filed by Meta Platforms Technologies, LLC; granted 2022-11-15.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20170007182A1 | Augmented and virtual reality display systems and methods for diagnosing a user using electrical potentials | 157 |
| 2 | US20170358136A1 | Focus adjusting virtual reality headset | 119 |
| 3 | US20170000329A1 | Augmented and virtual reality display systems and methods for determining optical prescriptions | 111 |
| 4 | US20170007115A1 | Augmented and virtual reality display systems and methods for diagnosing health conditions based on visual fi… | 97 |
| 5 | US20170007450A1 | Augmented and virtual reality display systems and methods for delivery of medication to eyes | 87 |
| 6 | US10345592B2 | Augmented and virtual reality display systems and methods for diagnosing a user using electrical potentials | 83 |
| 7 | US20170007799A1 | Augmented and virtual reality display platforms and methods for delivering health treatments to a user | 77 |
| 8 | US20170000343A1 | Augmented and virtual reality display systems and methods for determining optical prescriptions by imaging re… | 77 |
| 9 | US20170000325A1 | Augmented and virtual reality display systems and methods for diagnosing using occluder | 76 |
| 10 | US10345590B2 | Augmented and virtual reality display systems and methods for determining optical prescriptions | 74 |
Citation counts favour older filings within any searched corpus; treat this table as a map of influence on later filers, not a ranking of current technical importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three things stand out once the counts are broken down by geography, class and year.
A climb from one family in 2017 to seventeen in 2022, followed by a pullback, describes a field where the core architectural bets — pancake optics, varifocal correction — were placed and are now being defended rather than expanded.
With 57 US filings against 17 at the EPO and 12 via PCT, a design choice cleared for Europe or Asia-Pacific markets still needs separate US clearance — the receiving-office split is far from even.
A61B, A61F, A61M and A61N together cover a substantial share of the same 98 families, meaning much of the recent activity claims the optical hardware as a delivery mechanism for diagnosis or therapy, not display performance alone.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to vr display and optics systems, with the prior art for and against each one.
The ranking is concentrated at the top with a long tail of single-digit filers; recent-year momentum has cooled across the leaders tracked, several showing a full drop to zero in the latest year.
Assignees that built out early pancake-lens and varifocal portfolios show no new filings in the latest tracked year, consistent with the 2022 peak having passed rather than a still-rising curve.
Only one co-assignee pairing recurs in the dataset, between two related corporate entities under the same corporate family — cross-company collaboration on core optics claims is not a visible pattern here.
Beyond the US, EPO and PCT routes, Israel, Taiwan and Australia each carry only a handful of filings, suggesting the leading assignees treat those as selective rather than blanket coverage markets.
| Assignee | Recent year | YoY |
|---|---|---|
| Meta Platforms Technologies, LLC | 0 | -100% |
| Magic Leap, Inc. | 0 | -100% |
| LG Display Co., Ltd. | 0 | — |
| Oculus VR, LLC | 0 | — |
| National Yang Ming Chiao Tung University | 0 | — |
| Meta Platforms Technologies, LLC | 0 | — |
| KERDEMELIDIS ANDREW | 0 | — |
The filing data points to a field with an occupied core and a thinner edge — the next steps depend on whether you are clearing a design or looking for room to file.
With 92 of 98 families in G02B and 57 filed in the US, any pancake-lens or varifocal design headed for the US market needs claim-by-claim review against the most-cited records before committing to a design.
Search the G02B claim space in EurekaThe A61B/A61F/A61M/A61N overlap shows optics-plus-health claiming is an active strategy; a hardware team pairing a display with a diagnostic function should check whether that combination is already staked out.
Explore overlapping IPC classes in EurekaScreen-door-effect masking, latency compensation and frame weight distribution show thinner claim density than the core lens architectures — worth a dedicated prior-art pull before assuming the space is open.
Check white space in EurekaThe dataset of 98 patent families shows filing concentrated among a small group of assignees with recognisable names in pancake-lens and varifocal optics, including entities tied to Meta Platforms Technologies and Magic Leap, alongside display manufacturers like LG Display. However, recent-year momentum has cooled across the board — several of the leading assignees show zero filings in the latest tracked year. A ranking table is the more reliable way to see relative volume than any single company claim, since positions shift as new families publish.
A pancake lens folds the optical path using a partial reflector and a reflective polarizer so the lens-to-display distance shrinks, letting headsets get thinner and lighter than traditional Fresnel-lens designs. The representative filing in this dataset, US11500217B2 from Meta Platforms Technologies, describes exactly this architecture combined with an adjustable varifocal element. Because thinness and weight are persistent headset design pressures, pancake-lens claims account for a large share of the G02B filings tracked here.
Not on this evidence. Filings rose from a single family in 2017 to a peak of 17 in 2022, then declined, and recent-year momentum for the leading assignees shows drops to zero rather than continued growth. Publication lag of roughly eighteen months means the very latest year is always undercounted, but the shape of the curve — rise to a mid-period peak, then fall — is a stronger signal than any single recent data point. Treat this as a field where core architectures are claimed and defended rather than one still attracting a wave of new entrants.
The IPC composition shows heavy density in G02B (92 of 98 families) but comparatively thinner claiming around specific sub-problems named in the search terms themselves — screen-door-effect mitigation, motion-to-photon latency compensation, and headset weight distribution. These are documented technical concerns in the field's own literature but do not show the same claim density as the core pancake-lens and varifocal mechanisms. A prior-art search focused on these narrower mechanical and signal-processing angles is more likely to surface open claim territory than another pass at lens-stack architecture.
22 to 27 of the 98 families also carry A61B, A61F, A61M or A61N classifications, which cover diagnosis, implants, body-fluid devices and electrotherapy respectively. Several of the most-cited records in this corpus explicitly claim the headset as a diagnostic tool — for visual-field testing, optical prescription determination, or medication delivery to the eye. This reflects a filing strategy where display hardware gains a second, less crowded claim angle by being tied to a health application rather than to display quality alone.
Go past this page: query the whole vr display and optics systems corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.